# K992078: Vantage Exspect II

- Pathway: 510(k) (Traditional)
- Applicant: Adac Laboratories
- Decided: Sep 1, 1999 after 75 days
- Product code: KPS (System, Tomography, Computed, Emission)
- Device class: 2
- Regulation: 21 CFR 892.1200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K943596 (1995). 2 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K971878: Vantage 2.1 Exspect, Adac Laboratories (1997) Summary page 1.

## Most influential descendants
- K033735: Vantage Pro Attenuation Correction Device (2003), 0 descendants of its own

## Indications for use
Vantage ExSPECT II is intended to provide quality assurance enhancements to nuclear medicine images acquired using the ADAC Gamma Camera Systems.

Source page: https://510kreport.com/device/K992078
Methodology: https://510kreport.com/methodology
